** Shares of tech firm MKS Instruments MKSI.O rise nearly 7.5% to about $130.5 in early trading
** BofA raises co's PT to $150 from $110, a 23.7% upside on stock's last close
** Morgan Stanley raises co's PT to $151 from $120, a 24.5% upside
** "MKSI’s core differentiation is its combined equipment and chemistry offering, which competitors lack," BofA says
** Morgan Stanley says end markets will continue to strengthen, as it revises EPS estimates for FY26 to $8.90 from $8.02; expects FY27 EPS at $9.84
** 13 of 15 brokerages rate the stock "buy" or higher, one "hold" and one "sell"; their median PT is $125 - data compiled by LSEG
** Including session moves, shares up about 25% YTD
(Reporting by Parth Chandna)
((Parth.Chandna@thomsonreuters.com;))